TETERBORO, N.J., Sep 23, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Robert A. Hagemann,
Vice President and Chief Financial Officer, is scheduled to speak at the Banc of
America Securities 32nd Annual Investment Conference on Monday, September 23,
2002, at the Ritz Carlton, San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 9:45 a.m. Pacific Time.
An audio webcast of the presentation will be presented live during the
conference and will be available to registered analysts on the Banc of America
Securities' password secured site on the Internet at:
http://www.veracast.com/webcasts/BAS/32nd-annual-2002/id82104323.cfm. All others
may access the Quest Diagnostics website at: www.questdiagnostics.com. In
addition, the archived webcast will be available through Friday, October 11,
2002 at, at 5 p.m. Pacific Time.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2001 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Laure Park, Investors, +1-201-393-5030, or Gary Samuels, Media,
+1-201-393-5700, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
Copyright (C) 2002 PR Newswire. All rights reserved.